D07.39 — Carcinoma in situ of other female genital organs
Is D07.39 billable?
Yes — D07.39 is billable for FY2027. D07.39 is a valid, billable ICD-10-CM code at the highest level of specificity in its branch. D07.39 may be submitted for encounters from October 1, 2026 through September 30, 2027.
D07.39 at a glance
| Code | D07.39 |
|---|---|
| Description | Carcinoma in situ of other female genital organs |
| Billable | Yes |
| Code set | ICD-10-CM FY2027 |
| Valid for encounters | October 1, 2026 – September 30, 2027 |
Which MS-DRGs does D07.39 group to?
D07.39 sits in MDC 13 and helps define the logic of 3 MS-DRGs (version 44, FY2027). Which one a stay actually groups to also depends on procedures and secondary diagnoses.
- 731Uterine and Adnexa Procedures for Malignancy with MCCsurgical
- 732Uterine and Adnexa Procedures for Malignancy with CCsurgical
- 733Uterine and Adnexa Procedures for Malignancy without CC/MCCsurgical
Excludes1 — never code together — inherited from D07
The conditions below can never be reported together with D07.39 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.
- melanoma in situ of trunk (D03.5)
How long has D07.39 existed?
D07.39 has been in ICD-10-CM since at least FY2016, the earliest fiscal year on record here.
Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.